text.skipToContent text.skipToNavigation

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?
{{requestQuote.productName}}; {{requestQuote.form.productCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

 Bulk Order
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
{{ cartItemsCount }} 0
If not, click 'cancel'. You can also save this item for later.
Cancel
Popular Regions
All Regions

Imatinib

Product Code

TRC-I268023

CAS Number

152459-95-5

Product Format

Neat

Molecular Formula

C29 H31 N7 O

Molecular Weight

493.60

API Family

Imatinib Mesilate, Imatinib

Product Categories

TRC, Enzyme inhibitors, Enzyme inhibitors, API Reference Standards & Research Materials, Kinase Modulators, Kinase Inhibitors, Pharmaceutical and Veterinary Residue Reference Materials , Pharmaceutical, Veterinary Compound & Metabolite Reference Materials

Product Type

API

Alternate CAS Number

Labelled: 1092942-82-9

Price and availability

48-hour USA dispatch time
If Exact Weight packaging is selected, a certificate will be delivered with the product, which will indicate the mass of the material dispensed into the vial with a precision of up to 3 decimal places. Exceptions apply.
Request custom pack size quote

{{ favouriteItem.successMessage }}

View favourites

Product removed from your favourites

{{ addToCartData.mixPtRmWarning }}

Do you want to proceed?
{{requestQuote.productName}}; {{requestQuote.form.productCode}}

Thank you

We will respond to your enquiry shortly.

Something went wrong, please try again later.

Documentation

Where shall we send your requested CoA?
Part number:  {{ coaPopupData.packSize.code }}

{{ errors.first('lotNumber') }}

{{ errors.first('requestEmail') }}
LGC will use your email address only for the purposes of providing the requested document.
For information about our data processing activities, please visit our Privacy Notice.

{{ coaPopupData.serverError }}
Where shall we send your requested CoA?

Enter your email address and we'll email you the relevant CoA for lots:
{{ coaPopupData.packSize.coaSelectedLotNumbers }}

{{ errors.first('coaEmail') }}

 By entering your email address, you confirm that you give your consent to LGC to share information in connection with the product(s) above and other similar products from time to time. LGC will process your personal data in accordance with all applicable data protection rules and regulations. For information relating to LGC’s data processing activities, please visit our Privacy Policy below (see footer).
Cancel
Thank you

We will be sending the CoA to your email address  {{ coaEmailPopupData.userEmail }}

Thank you

Your request has been sent to our sales team to process.

Product Information

Product Notes

Imatinib is a 2-phenyl amino pyrimidine derivative that functions as a tyrosine kinase inhibitor, including the Bcr-AbI pathway. It is an orally bioactive anti-cancer agent used in the treatment of cancers such as chronic myelogenous leukaemia (CML) and acute lymphocytic leukaemia (ALL), all of which are Philadelphia chromosome-positive (Ph+), as well as hypereosinophilic syndrome (HES) and certain types of gastrointestinal stromal tumours (GIST).  
References
[1] Deininger MW. Milestones and monitoring in patients with CML treated with imatinib. Education Program Book; 50th ASH Conference; 2008. pp. 419–426.
[2] Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996. 1996;2:561–566. doi: 10.1038/nm0596-561.
[3] Deininger MW, Druker BJ: Specific targeted therapy of chronic myelogenous leukemia with imatinib. Pharmacol Rev. 2003 Sep;55(3):401-23. Epub 2003 Jul 1.
[4] Droogendijk HJ, Kluin-Nelemans HJ, van Doormaal JJ, Oranje AP, van de Loosdrecht AA, van Daele PL: Imatinib mesylate in the treatment of systemic mastocytosis: a phase II trial. Cancer. 2006 Jul 15;107(2):345-51.

Product Data

Analyte Name

Imatinib

CAS Number

152459-95-5

Molecular Formula

C29 H31 N7 O

Molecular Weight

493.60

Accurate Mass

493.259

SMILES

CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1

InChI

InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)

IUPAC

4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Alternate CAS Number

Labelled: 1092942-82-9

Storage & Transport Information

Storage Temperature

-20°C

Shipping Temperature

Room Temperature

Country of Origin

CANADA

Product Attributes

Product Type

API

Product Format

Neat

API Family

Imatinib Mesilate; Imatinib

Punchout session timeout warning

Your punchout session will expire in1 min59 sec.

Select "Continue session" to extend your session.